Peptides DB
Research-centric peptide and protocol reference hub
Study 27 of 28DSIP literatureThe Journal of clinical endocrinology and metabolism · ObservationalHigh-impact journal1994

Diurnal rhythm of plasma delta-sleep-inducing peptide in humans: evidence for positive correlation with body temperature and negative correlation with rapid eye movement and slow wave sleep.

This study found that plasma DSIP levels follow a diurnal rhythm and are lower during rapid eye movement sleep, but do not rise significantly during slow wave sleep.

Read at The Journal of clinical endocrinology and metabolismAdd to compare

Where it sits

this study against the rest of the dsip corpus
7
Preclinical
19
Observational · this one
0
Open-label
0
Randomised
2
Reviews

Summary and findings

This study measured plasma delta-sleep-inducing peptide (DSIP) levels in 12 normal volunteers over 24 hours. The researchers found a diurnal rhythm with maximum levels at 1500 h and minimum at 0100 h. DSIP levels were lower during rapid eye movement sleep and somewhat lower during slow wave sleep compared to awake values.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
DSIP-LI levels were lower in rapid eye movement sleep (P < 0.005).1994

Abstract

The authors’ words, as The Journal of clinical endocrinology and metabolism supplied them

Since delta-sleep-inducing peptide (DSIP) was isolated in 1977, numerous reports have suggested that this nonapeptide stimulates delta-sleep [slow wave sleep (SWS)]. Although DSIP-like immunoreactivity (DSIP-LI) has been found in the serum of many animals and man, its diurnal rhythm and relation to sleep stages have not been well defined. We hypothesized that circulating levels of this putative sleep hormone would be highest at night and would probably be elevated before or during episodes of SWS. We, therefore, measured plasma DSIP-LI levels every 30 min for 24 h in 12 normal volunteers in whom we obtained simultaneous polygraphic recordings. We found a distinct diurnal rhythm for plasma DSIP-LI levels, with the maximum at 1500 h and the minimum at 0100 h. DSIP-LI levels were substantially lower in rapid eye movement sleep (P < 0.005) and somewhat lower in SWS (P < 0.05) compared to awake values. DSIP-LI levels did not rise before, during, or after a significant percentage of episodes of SWS. We found, however, that the diurnal rhythm of DSIP-LI closely followed that of body temperature with a high degree of correlation (r2 = 0.66; P < 0.0001). We conclude that endogenous elevations of circulating DSIP may be associated with suppression of slow wave and rapid eye movement sleep, and that the circadian rhythm of this peptide is coupled directly or indirectly to that of body temperature.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the DSIP corpus

BPresence of delta-sleep-inducing peptide-like material in human milk.The Journal of clinical endocrinology and metabolism · 1984 · 30 ng/ml DSIP-like immunoreactivity in colostrum.HumanCValidation of SARS-CoV-2 neutralization assay using VSV-based pseudovirus system.Analytical biochemistry · 2026 · Limit of quantification (LOQ) was determined to be 125 ng of mAb BD-604.In vitroBA U-shaped relationship between perceived chronic stress and the approach motivation: evidence from resting-state EEG.Stress (Amsterdam, Netherlands) · 2026 · n=60 · β = 0.33, 95% CI [0.0003, 0.0036], p = 0.021 for delta power.HumanB'In Every River, in Every Lake': Impacts of Beaver Population Change on Indigenous Livelihoods and Wellbeing in the Inuvialuit Settlement Region, Western Canadian Arctic.Human ecology: an interdisciplinary journal · 2026 · n=25HumanDComprehensive security review and challenges for smart and power grids to prevent cyber-attacks in IoTs.MethodsX · 2026reviewCDesign, synthesis, and evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates for enhanced photodynamic therapy in triple-negative breast cancer.Bioorganic & medicinal chemistry letters · 2026 · IC50 values of 51.16 ± 1.93 μM and 49.65 ± 2.50 μM for conjugates 13a and 13d.In vitro